This review aims to outline the most up-to-date knowledge of pancreatic adenocarcinoma
risk, diagnostics, treatment and outcomes, while identifying gaps that aim to stimulate further …

Mammalian cells can release different types of extracellular vesicles (EVs), including
exosomes, microvesicles, and apoptotic bodies. Accumulating evidence suggests that EVs …

The last two decades of cancer research have been devoted in two directions:(1)
understanding the mechanism of carcinogenesis for an effective treatment, and (2) …

Pancreatic cancer (PC) is one of the most lethal malignancies. Recent studies indicate that
patients with incidentally diagnosed PC have better prognosis than those with symptoms …

Pancreatic ductal adenocarcinoma (PDAC) is fatal disease and one of the major causes of
death among cancer patients. Diagnosis of PDAC during the early stages of cancer using …

Objective: To examine potential biomarkers in Lewis negative patients with pancreatic
cancer. Background: Carbohydrate antigen 19–9 (CA19–9) is currently the most important …

MicroRNAs (miRNAs) represent a class of non-coding RNAs that exert pivotal roles in the
regulation of gene expression at the post-transcriptional level. MiRNAs are involved in many …

The differential expression of microRNAs (miRNAs) in plasma of pancreatic cancer (PC)
patients may act as a diagnostic biomarker. A four-stage study was performed to identify …

MicroRNAs (miRNAs) are small, non-coding RNAs that regulate gene expression
predominantly by inhibiting transcription and/or promoting degradation of target mRNAs also …

Background Pancreatic ductal adenocarcinoma (PDAC) is a lethal neoplasm because of
difficulties in early detection. Several studies have recently suggested that exosomes may …